Rx Medicare

SRI International, an independent, nonprofit research and development organization, has announced that that it will screen a library of well-characterized drugs against the 2009 H1N1 influenza A virus, previously known as “swine flu.” The work will be performed under a resource contract from the Division of Microbiology and Infectious Diseases (DMID) in the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Read More…

Related Posts

• SRI International To Screen Drugs That Fight 2009 H1N1 Influenza A
• USDA Conducting Confirmatory Testing On Possible Detection Of 2009 Pandemic H1N1 Influenza In U.S. Swine
• Swine Flu: NIAID Set To Launch Clinical Trials To Test 2009 H1N1 Influenza Vaccine Candidates
• 15 Countries Report 615 Swine Flu (influenza A H1N1) Cases Of Infection Among Humans, 2nd May 2009
• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• Swine Influenza Daily Update: 24 December 2009, Wales
• Swine Influenza Daily Update: 29 December 2009, Wales
• Swine Influenza Daily Update: 16 December 2009, Wales
• Statement By The Welsh Assembly Government On Latest Developments In Respect Of The Influenza A (H1N1) Swine Flu Pandemic
• Swine Influenza Daily Update: 01 December 2009, Wales
• Swine Influenza Daily Update: 06 December 2009, Wales
• Swine Influenza Daily Update: 24 November 2009, Wales
• Groups At High Risk Of H1N1 Influenza A Should Avoid Travelling To 2009 HAJJ
• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• CSL Biotherapies Obtains FDA Licensure For Use Of Its Thimerosal-Free Pandemic Influenza A (H1N1) 2009 Monovalent Vaccine In Children

Tags: 2009, drugs, efficacy, fight, h1n1, influenza, international, screened, swine

This entry was posted on Sunday, May 17th, 2009 at 8:05 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.